Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Artificial Intelligence & Technology ETF (AIQ) vs Alexandria Real Estate Equities Inc (ARE) Price & Performance

Global X Artificial Intelligence & Technology ETF
Alexandria Real Estate Equities Inc

Price performance

Price movement over the last 24 hours

Key statistics

Global X Artificial Intelligence & Technology ETF vs Alexandria Real Estate Equities Inc — how do they compare? Global X Artificial Intelligence & Technology ETF trades at $62.53, while Alexandria Real Estate Equities Inc trades at $48 (market cap $8.61B). The key difference: Alexandria Real Estate Equities Inc pays a 5.83% dividend while Global X Artificial Intelligence & Technology ETF pays none, and Global X Artificial Intelligence & Technology ETF is trading nearer its 52-week high, Alexandria Real Estate Equities Inc nearer its low. Which is the better fit depends on your goals.

AIQARE
Sector
Sector/ThematicReal Estate
52-Week High
$70.14$87.45
52-Week Low
$43.28$40.41
Market Cap
$8.61B
Enterprise Value
$21.07B
Dividend Yield
5.83%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Artificial Intelligence & Technology ETF

AIQ trades at $63.84, up 3.22% with a neutral technical signal. The ETF shows strong momentum with moving averages indicating bullish sentiment while oscillators remain neutral. Recent performance highlights include turning $10,000 into $13,400 over six months, outperforming broader market indices. The fund has gained attention for its AI-focused strategy amid expanding market interest beyond mega-cap technology stocks.

The outlook remains positive as AI adoption accelerates, though valuations require monitoring. Key risks include thematic ETF concentration and fee structure considerations. Institutional interest in AI infrastructure spending supports long-term growth potential, but market volatility around AI stock rotations presents near-term challenges.

Alexandria Real Estate Equities Inc

Alexandria Real Estate Equities (ARE) trades at $49.41, down 6.03% over 24 hours amid bearish technical signals and mixed fundamentals. The stock shows negative profitability with -37.09% net income margin and -6.43% ROE, though valuation metrics like P/B of 0.55 suggest potential undervaluation. Recent earnings have been inconsistent with two misses in the last four quarters. The company maintains strong operational cash flow of $1.41B and declared a $0.72 dividend for Q2 2026.

ARE faces headwinds from declining occupancy guidance and net losses, but analyst consensus remains cautiously optimistic with a $51 price target and 37.5% buy ratings. Key risks include high debt levels (40.79% debt-to-asset ratio) and uneven demand in life science real estate. The stock's current position near support at $49 offers potential for recovery if operational improvements materialize.

Returns comparison

Trailing returns across standard periods

About Global X Artificial Intelligence & Technology ETF

AIQ invests in companies that benefit from the development and utilization of artificial intelligence. It focuses on hardware, software, and data giants at the center of the AI revolution, including NVIDIA, Meta, and Broadcom.

Read more on AIQ

About Alexandria Real Estate Equities Inc

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.

Read more on ARE